Cited by 1,076COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

Open access

Xiong, Yong, Liu, Yuan, Cao, Liu, Wang, Dehe, Guo, Ming, Jiang, Ao, Guo, Dong, Hu, Wenjia, Yang, Jiayi, Tang, Zhidong, Wu, Honglong, Lin, Yongquan, Zhang, Meiyuan, Zhang, Qi, Shi, Mang, Liu, Yingle, Zhou, Yu, Lan, Ke, Chen, Yu·2020·Emerging Microbes & Infections

DOI 10.1080/22221751.2020.1747363PMC PMC7170362

Open this paper in CoChat — free account

Abstract

Circulating in China and 158 other countries and areas, the ongoing COVID-19 outbreak has caused devastating mortality and posed a great threat to public health. However, efforts to identify effectively supportive therapeutic drugs and treatments has been hampered by our limited understanding of host immune response for this fatal disease. To characterize the transcriptional signatures of host inflammatory response to SARS-CoV-2 (HCoV-19) infection, we carried out transcriptome sequencing of the RNAs isolated from the bronchoalveolar lavage fluid (BALF) and peripheral blood mononuclear cells (PBMC) specimens of COVID-19 patients. Our results reveal distinct host inflammatory cytokine profiles to SARS-CoV-2 infection in patients, and highlight the association between COVID-19 pathogenesis and excessive cytokine release such as CCL2/MCP-1, CXCL10/IP-10, CCL3/MIP-1A, and CCL4/MIP1B. Furthermore, SARS-CoV-2 induced activation of apoptosis and P53 signalling pathway in lymphocytes may be the cause of patients' lymphopenia. The transcriptome dataset of COVID-19 patients would be a valuable resource for clinical guidance on anti-inflammatory medication and understanding the molecular mechansims of host response.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1080/22221751.2020.1747363

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figure 1. Genome-wide profiling of gene expression in BALF and PBMC of COVID-19 patients. (A) Experimental design. PBMC and BALF were prepared from patients or control. Total RNA was extracted and analysed by RNA-seq to identify differentially expressed genes implicated in COVID-19 disease pathogenesis. (B, C) Heat map of genes significantly up-regulated and down-regulated (fold change > 2) in COVID-19 patients BALF (B, WHU01-2 vs. Ctrl1-3) and PBMC (C, P1-3 vs. N1-3) compared to controls, respectively. (D-F) RNA-seq signals in PBMC patients (P1, P2, P3) and healthy controls (N1, N2, N3) for 3 genes: IL6 (D), IL6R (E), and TP53 (F), respectively. The scale on the y axis indicates the read density per million of total normalized reads.CC BY · PubMed Central

Figure 2. GO-term and KEGG pathway enrichment of up-regulated expressed genes in BALF and PBMC of COVID-19 patients. (A) GO-term functional enrichment by 3 categories (BP, MF, CC) and KEGG pathway analysis were performed for up-regulated genes in COVID-19 patients BALF. (B) Same as (A) for up-regulated genes in COVID-19 patients PBMC.CC BY · PubMed Central

Figure 3. GO-term and KEGG pathway enrichment of down-regulated expressed genes in BALF and PBMC of COVID-19 patients. (A) GO-term functional enrichment by 3 categories (BP, MF, CC) and KEGG pathway analysis were performed for down-regulated genes in COVID-19 patients BALF. (B) Same as (A) for down-regulated genes in COVID-19 patients PBMC.CC BY · PubMed Central

Figure 4. Inflammatory cytokines expression in COVID-19 patients. Heat map depicting inflammatory cytokine genes expression in COVID-19 patients BALF (A, WHU01-02 vs. Ctrl1-3) and PBMC (B, P1-3 vs. N1-3) compared with control. Genes significantly up-regulated and down-regulated are labelled with asterisks.CC BY · PubMed Central

Figure 5. Apoptosis-related pathway in PBMC. The heatmaps show the expression levels of differentially expressed genes in different signaling pathways, including (A) autophagy (- animal species) signal pathway, (B) apoptosis signal pathway, (C) p53 signaling pathway. Genes significantly up-regulated and down-regulated are labelled with asterisks.CC BY · PubMed Central

Figure 6. Comparison of differentially expressed genes in BALF and PBMC. (A) Venn diagram showing the number of changed genes with same or different trends between BALF and PBMC samples. (B) Heat map depicting the scaled gene expression changes with same or different trends between BALF and PBMC samples.CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citation
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citation
Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Self-citation
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463

Show all 53 references

Sorted by citations

Items 201–300 of 1,000

Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis
Hazra, S., Chaudhuri, A. G., Tiwary, B. K., & Chakrabarti, N. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118096 · Cited by 59
Does SARS-CoV-2 Trigger Stress-Induced Autoimmunity by Molecular Mimicry? A Hypothesis
Cappello, F., Marino, A., Dieli, F., de Macario, E. C., & Macario, A. J. L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072038 · Cited by 60
Peripheral Blood Examination Findings in SARS-CoV-2 Infection
Nazarullah, A. N., Liang, C., Villarreal, A., Higgins, R. A., & Mais, D. D. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa108 · Cited by 59
Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2
Islam, A. B. M. M. K., Khan, M. A., Ahmed, R., Hossain, M. S., Kabir, S. M. T., Islam, M. S., & Siddiki, A. Z. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-020-02695-0 · Cited by 58
Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19
Liu, Y., Tan, W., Chen, H., Zhu, Y., Wan, L., Jiang, K., Guo, Y., Tang, K., Xie, C., Yi, H., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05792-7 · Cited by 58
Self-citation
Interplay between SARS‐CoV‐2 and human long non‐coding RNAs
Moazzam‐Jazi, M., Lanjanian, H., Maleknia, S., Hedayati, M., & DANESHPOUR, M. S. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16596 · Cited by 58
Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.666693 · Cited by 60
Tissue factor expression, extracellular vesicles, and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus
Mackman, N., Grover, S. P., & Antoniak, S. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15509 · Cited by 62
The role of neutrophil-lymphocyte ratio and lymphocyte–monocyte ratio in the prognosis of type 2 diabetics with COVID-19
Liu, G., Zhang, S., Hu, H., Liu, T., & Huang, J. (2020) · Scottish Medical Journal · doi:10.1177/0036933020953516 · Cited by 57
Clinical laboratory evaluation of COVID-19
Chen, Z., Xu, W., Ma, W., Shi, X., Li, S., Hao, M., Fang, Y., & Zhang, L. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.04.022 · Cited by 57
Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures
Kulasinghe, A., Tan, C. W., Miggiolaro, A. F. R. D. S., Monkman, J. H., Sadeghirad, H., Bhuva, D. D., Motta, J. D. S., de Paula, C. B. V., Nagashima, S., Baena, C. P., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.01881-2021 · Cited by 56
SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements
Marston, J. L., Greenig, M., Singh, M., Bendall, M. L., Duarte, R. R. R., Feschotte, C., Iñiguez, L., & Nixon, D. F. (2021) · JCI Insight · doi:10.1172/jci.insight.147170 · Cited by 58
Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry
Li, Z., Peng, M., Chen, P., Liu, C., Hu, A., Zhang, Y., Peng, J., Liu, J., Li, Y., Li, W., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.008 · Cited by 57
Bronchoalveolar lavage: role in the evaluation of pulmonary interstitial disease
Hogea, P., Tudorache, E., Pescaru, C. C., Marc, M. S., & Oancea, C. I. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1806063 · Cited by 56
Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection
Campana, P., Parisi, V., Leosco, D., Bencivenga, D., Ragione, F. D., & Borriello, A. (2020) · Cells · doi:10.3390/cells9092046 · Cited by 55
Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators
Ricci, D., Etna, M. P., Rizzo, F., Sandini, S., Severa, M., & Coccia, E. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137017 · Cited by 61
SARS-CoV-2: Viral Loads of Exhaled Breath and Oronasopharyngeal Specimens in Hospitalized Patients with COVID-19
Malik, M., Kunze, A.-C., Bahmer, T., Herget‐Rosenthal, S., & Kunze, T. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.07.012 · Cited by 54
Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets
Yapasert, R., Khaw-on, P., & Banjerdpongchai, R. (2021) · Molecules · doi:10.3390/molecules26247459 · Cited by 55
Detection of SARS-CoV-2 genome and whole transcriptome sequencing in frontal cortex of COVID-19 patients
Gagliardi, S., Poloni, T. E., Pandini, C., Garofalo, M., Dragoni, F., Medici, V., Davin, A., Visoná, S. D., Moretti, M., Sproviero, D., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.05.012 · Cited by 55
Programmed cell death: the pathways to severe COVID-19?
Bader, S. M., Cooney, J. P., Pellegrini, M., & Doerflinger, M. (2022) · Biochemical Journal · doi:10.1042/bcj20210602 · Cited by 55
COVID-19 and human reproduction: A pandemic that packs a serious punch
Anifandis, G., Tempest, H. G., Oliva, R., Swanson, G., Simopoulou, M., Easley, C. A., Primig, M., Messini, C. I., Turek, P. J., Šutovský, P., et al. (2021) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2020.1855271 · Cited by 53
COVID-19-associated diarrhea
Megyeri, K., Dernovics, Á., Al-Luhaibi, Z. I. I., & Rosztoczy, A. I. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i23.3208 · Cited by 57
Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19
Paolini, A., Borella, R., Biasi, S. D., Neroni, A., Mattioli, M., Tartaro, D. L., Simonini, C., Franceschini, L., Cicco, G., Piparo, A. M., et al. (2021) · Cells · doi:10.3390/cells10071585 · Cited by 55
Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples
Biji, A., Khatun, O., Swaraj, S., Narayan, R., Rajmani, R. S., Sardar, R., Satish, D., Mehta, S., Bindhu, H., Jeevan, M., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103525 · Cited by 54
SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities
Osuchowski, M. F., Aletti, F. M., Cavaillon, J., Flohé, S. B., Giamarellos‐Bourboulis, E. J., Huber-Lang, M. S., Relja, B., Skirecki, T., Szabó, A., & Maegele, M. (2020) · Shock · doi:10.1097/shk.0000000000001565 · Cited by 50
ADAM17/MMP inhibition prevents neutrophilia and lung injury in a mouse model of COVID-19
Lartey, N. L., Valle-Reyes, S., Vargas-Robles, H., Jiménez-Camacho, K. E., Guerrero-Fonseca, I. M., Castellanos-Martínez, R., Montoya-García, A., García-Cordero, J., Cedillo-Barrón, L., Nava, P., et al. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3cova0421-195rr · Cited by 52
Emerging Paradigms in Type 2 Immunity
Hammad, H., Debeuf, N., Aegerter, H., Brown, A. S., & Lambrecht, B. N. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101320-030339 · Cited by 56
Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a theoretical perspective
Hamidi, S. H., Kadamboor Veethil, S., & Hamidi, S. H. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00255-x · Cited by 50
The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients
Bordoni, V., Tartaglia, E., Sacchi, A., Fimia, G. M., Cimini, E., Casetti, R., Notari, S., Grassi, G., Marchioni, L., Bibas, M., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.02.019 · Cited by 54
Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases
Chaudhry, M. Z., Eschke, K., Hoffmann, M., Grashoff, M., Abassi, L., Kim, Y., Brunotte, L., Ludwig, S., Kröger, A., Klawonn, F., et al. (2022) · Journal of Virology · doi:10.1128/jvi.02186-21 · Cited by 51
Tissue factor in COVID-19-associated coagulopathy
Subramaniam, S., Kothari, H., & Bosmann, M. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2022.09.025 · Cited by 53
Depletion and Dysfunction of Dendritic Cells: Understanding SARS-CoV-2 Infection
Chang, T., Yang, J., Deng, H., Chen, D., Yang, X., & Tang, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843342 · Cited by 57
Self-citation
Stroke Associated with COVID-19 Vaccines
Kakovan, M., Shirkouhi, S. G., Zarei, M., & Andalib, S. (2022) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2022.106440 · Cited by 54
Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
Costiniuk, C. T., & Jenabian, M.-A. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.008 · Cited by 50
Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities
Nashiry, M. A., Sumi, S. S., Islam, S., Quinn, J. M. W., & Moni, M. A. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa426 · Cited by 50
The role of autophagy in controlling SARS‐CoV‐2 infection: An overview on virophagy‐mediated molecular drug targets
Sargazi, S., Sheervalilou, R., Rokni, M., Shirvaliloo, M., Shahraki, O., & Rezaei, N. (2021) · Cell Biology International · doi:10.1002/cbin.11609 · Cited by 51
Susceptibility to COVID-19 in Pregnancy, Labor, and Postpartum Period: Immune System, Vertical Transmission, and Breastfeeding
Vale, A. J. M., Fernandes, A. C. L., Gúzen, F. P., Pinheiro, F. I., de Azevedo, E. P., & Cobucci, R. N. (2021) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2021.602572 · Cited by 52
COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications
Lim, M. S., & McRae, S. J. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103529 · Cited by 50
Myeloid cell interferon responses correlate with clearance of SARS-CoV-2
Singh, D. K., Aladyeva, E., Das, S., Singh, B., Esaulova, E., Swain, A., Ahmed, M., Cole, J., Moodley, C., Mehra, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28315-7 · Cited by 47
The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach
Najafi, S., Rajaei, E., Moallemian, R., & Nokhostin, F. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05376-x · Cited by 53
An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages
Motamedi, H., Ari, M. M., Dashtbin, S., Fathollahi, M., Hossainpour, H., Alvandi, A., Moradi, J., & Abiri, R. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107763 · Cited by 51
ADAR Editing in Viruses: An Evolutionary Force to Reckon with
Piontkivska, H., Wales-McGrath, B. D., Miyamoto, M. M., & Wayne, M. L. (2021) · Genome Biology and Evolution · doi:10.1093/gbe/evab240 · Cited by 51
Adaptive homeostasis and the p53 isoform network
Mehta, S. Y., Campbell, H. G., Drummond, C. J., Li, K., Murray, K., Slatter, T. L., Bourdon, J., & Braithwaite, A. W. (2021) · EMBO Reports · doi:10.15252/embr.202153085 · Cited by 50
Sarcopenia as potential biological substrate of long COVID‐19 syndrome: prevalence, clinical features, and risk factors
Martone, A. M., Tosato, M., Ciciarello, F., Galluzzo, V., Zazzara, M. B., Pais, C., Savera, G., Calvani, R., Marzetti, E., Robles, M. C., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12931 · Cited by 49
NSUN2-mediated m 5 C methylation of IRF3 mRNA negatively regulates type I interferon responses during various viral infections
Wang, H., Feng, J., Zeng, C., Liu, J., Fu, Z., Wang, D., Wang, Y., Zhang, L., Li, J., Jiang, A., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2178238 · Cited by 49
Self-citation
Risk stratification by long non‐coding RNAs profiling in COVID‐19 patients
Cheng, J., Zhou, X. P., Feng, W., Jia, M., Zhang, X., An, T., Luan, M., Pan, Y., Zhang, S., Zhou, Z., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16444 · Cited by 48
Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19
Le, B. L., Andreoletti, G., Oskotsky, T., Vallejo-Gracia, A., Rosales, R., Yu, K., Kosti, I., Leon, K. E., Bunis, D. G., Li, C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91625-1 · Cited by 51
Upregulation of Human Endogenous Retroviruses in Bronchoalveolar Lavage Fluid of COVID-19 Patients
Kitsou, K. S., Kotanidou, A. N., Paraskevis, D. N., Karamitros, T., Katzourakis, A., Tedder, R. S., Hurst, T. P., Sapounas, S., Kotsinas, A., Gorgoulis, V. G., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01260-21 · Cited by 47
Weighted Gene Co-Expression Network Analysis Combined with Machine Learning Validation to Identify Key Modules and Hub Genes Associated with SARS-CoV-2 Infection
Karami, H., Derakhshani, A., GhasemiGol, M., Fereidouni, M., Miri‐Moghaddam, E., Baradaran, B., Tabrizi, N. J., Najafi, S., Solimando, A. G., Marsh, L. M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163567 · Cited by 48
Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis
Quan, C., Li, C., Ma, H., Li, Y., & Zhang, H. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-20 · Cited by 49
SARS‐CoV ‐2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad
Amor, S., Baker, D., Khoury, S. J., Schmierer, K., & Giovanonni, G. (2020) · Annals of Neurology · doi:10.1002/ana.25770 · Cited by 48
Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19
Morenikeji, O. B., Bernard, K., Strutton, E. A., Wallace, M., & Thomas, B. N. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.582953 · Cited by 46
COVID‐19‐related coagulopathy: A review of pathophysiology and pharmaceutical management
Vajari, M. K., Shirin, M., Pourbagheri‐Sigaroodi, A., Akbari, M. E., Abolghasemi, H., & Bashash, D. (2021) · Cell Biology International · doi:10.1002/cbin.11623 · Cited by 48
Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact
Zhang, S., Asquith, B., Szydlo, R., Tregoning, J. S., & Pollock, K. M. (2021) · Immunotherapy Advances · doi:10.1093/immadv/ltab015 · Cited by 49
Secondary infections in critically ill patients with COVID-19
Grasselli, G., Cattaneo, E., & Florio, G. (2021) · Critical Care · doi:10.1186/s13054-021-03672-9 · Cited by 47
Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions
Abdelmoaty, M. M., Yeapuri, P., Machhi, J., Olson, K. E., Shahjin, F., Kumar, V. S., Zhou, Y., Liang, J., Pandey, K., Acharya, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741502 · Cited by 47
Self-citation
Neutrophil-Dependent Immunity During Pulmonary Infections and Inflammations
Effah, C. Y., Drokow, E. K., Agboyibor, C., Ding, L., He, S., Liu, S., Akorli, S. Y., Nuamah, E., Sun, T., Zhou, X., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.689866 · Cited by 51
Genome-Wide Profiling Reveals Alternative Polyadenylation of Innate Immune-Related mRNA in Patients With COVID-19
An, S., Li, Y., Lin, Y., Chu, J., Su, J., Chen, Q., Wang, H., Pan, P., Zheng, R., Li, J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.756288 · Cited by 46
Self-citation
Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019
da Silva, S. R., Ju, E., Meng, W., Mondolfi, A. E. P., Đačić, S., Green, A. R., Bryce, C., Grimes, Z., Fowkes, M. E., Sordillo, E. M., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab195 · Cited by 46
Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?
Pashaei, Y. (2021) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.03.010 · Cited by 48
Elevated interleukin (IL)-6 as a predictor of disease severity among Covid-19 patients: a prospective cohort study
Nikkhoo, B., Mohammadi, M., Hasani, S., Sigari, N., Borhani, A., Ramezani, C., Charajoo, A., Badri, S., Rostami, F., Etemadi, M., et al. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08294-w · Cited by 46
SARS-CoV-2 RNA elements share human sequence identity and upregulate hyaluronan via NamiRNA-enhancer network
Li, W., Yang, S., Xu, P., Zhang, D., Tong, Y., Chen, L., Jia, B., Li, A., Lian, C., Ru, D., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103861 · Cited by 46
Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis
Adhami, M., Sadeghı, B., Rezapour, A., Haghdoost, A. A., & MotieGhader, H. (2021) · BMC Biotechnology · doi:10.1186/s12896-021-00680-z · Cited by 44
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity
Bui, L. T., Winters, N. I., Chung, M.-I., Joseph, C., Gutierrez, A. J., Habermann, A. C., Adams, T. S., Schupp, J. C., Poli, S., Peter, L. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24467-0 · Cited by 45
Neutrophils at the crossroads of acute viral infections and severity
Rawat, S., Vrati, S., & Banerjee, A. K. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100996 · Cited by 49
COVID-19: systemic pathology and its implications for therapy
Shen, Q., Li, J., Zhang, Z., Guo, S., Wang, Q., An, X., & Chang, H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.65911 · Cited by 51
Immunotoxic role of organophosphates: An unseen risk escalating SARS-CoV-2 pathogenicity
Rajak, P., Ganguly, A., Sarkar, S., Mandi, M., Dutta, M., Podder, S., Khatun, S., & Roy, S. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112007 · Cited by 46
The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19
Delshad, M., Tavakolinia, N., Pourbagheri‐Sigaroodi, A., Safaroghli‐Azar, A., Bagheri, N., & Bashash, D. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107586 · Cited by 49
Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs
Gupta, A., & Gupta, G. S. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04107-3 · Cited by 45
Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection
Fröberg, J., & Diavatopoulos, D. A. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000724 · Cited by 45
Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways
Amini‐Farsani, Z., Yadollahi‐Farsani, M., Arab, S., Forouzanfar, F., Yadollahi, M., & Asgharzade, S. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108071 · Cited by 45
SARS-CoV-2 Membrane Glycoprotein M Triggers Apoptosis With the Assistance of Nucleocapsid Protein N in Cells
Ren, Y., Wang, A., Fang, Y., Shu, T., Wu, D., Wang, C., Huang, M., Min, J., Jin, L., Zhou, W., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.706252 · Cited by 45
Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets
Cheng, K., Martin‐Sancho, L., Pal, L. R., Pu, Y., Riva, L., Yin, X., Sinha, S., Nair, N. U., Chanda, S. K., & Ruppin, E. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110260 · Cited by 43
The Host Response to Viral Infections Reveals Common and Virus-Specific Signatures in the Peripheral Blood
Tsalik, E. L., Fiorino, C., Aqeel, A., Liu, Y., Henao, R., Ko, E. R., Burke, T. W., Reller, M. E., Bodinayake, C. K., Nagahawatte, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741837 · Cited by 52
Self-citation
Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection
Banaganapalli, B., Alrayes, N. M., Awan, Z. A., Alsulaimany, F. A. S., Alamri, A. S., Elango, R., Malik, M. Z., & Shaik, N. A. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104570 · Cited by 44
Exploiting the molecular basis of age and gender differences in outcomes of SARS-CoV-2 infections
Mercatelli, D., Pedace, E., Veltri, P., Giorgi, F. M., & Guzzi, P. H. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.07.002 · Cited by 42
Genome and epigenome editing identify CCR9 and SLC6A20 as target genes at the 3p21.31 locus associated with severe COVID-19
Yao, Y., Ye, F., Li, K., Xu, P., Tan, W., Feng, Q., & Rao, S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00519-1 · Cited by 44
The Immunopathology of COVID-19 and the Cannabis Paradigm
Paland, N., Pechkovsky, A., Aswad, M., Hamza, H., Popov, T., Shahar, E., & Louria‐Hayon, I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631233 · Cited by 46
Traditional Uses, Pharmacological Effects, and Molecular Mechanisms of Licorice in Potential Therapy of COVID-19
Zhang, Q., Huang, H., Qiu, M., Wu, Z., Xin, Z.-C., Cai, X., Shang, Q., Lin, J., Zhang, D., & Han, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.719758 · Cited by 44
Self-citation
A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization
Johnson, B. S., & Laloraya, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.014 · Cited by 42
Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients
Rícci, A., Pagliuca, A., D’Ascanio, M., Innammorato, M., Vitis, C. D., Mancini, R., Giovagnoli, S., Facchiano, F., Sposato, B., Anibaldi, P., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01666-3 · Cited by 43
A Pharmacological Interactome between COVID-19 Patient Samples and Human Sensory Neurons Reveals Potential Drivers of Neurogenic Pulmonary Dysfunction
Ray, P. R., Wangzhou, A., Ghneim, N., Yousuf, M. S., Paige, C. A., Tavares‐Ferreira, D., Mwirigi, J. M., Shiers, S. I., Sankaranarayanan, I., McFarland, A. J., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.078 · Cited by 42
Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients
Nossent, E. J., Schuurman, A. R., Reijnders, T. D. Y., Saris, A., Jongerius, I., Blok, S. G., de Vries, H. J., Duitman, J., Noordegraaf, A. V., Meijboom, L. J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.664209 · Cited by 43
Value of swab types and collection time on SARS-COV-2 detection using RT-PCR assay
Liu, M., Li, Q., Zhou, J., Ai, W., Zheng, X., Zeng, J., Liu, Y., Xiang, X., Guo, R., Li, X., et al. (2020) · Journal of Virological Methods · doi:10.1016/j.jviromet.2020.113974 · Cited by 42
Self-citation
miR-1207-5p Can Contribute to Dysregulation of Inflammatory Response in COVID-19 via Targeting SARS-CoV-2 RNA
Bertolazzi, G., Cipollina, C., Benos, P. V., Tumminello, M., & Coronnello, C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.586592 · Cited by 42
Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection
Khoshkam, Z., Aftabı, Y., Stenvinkel, P., Lawrence, B. P., Habibi-Rezaei, M., Ichihara, G., & Fereidouni, S. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2020.12.013 · Cited by 45
Viral strategies for circumventing p53: the case of severe acute respiratory syndrome coronavirus
Cardozo, C. M., & Hainaut, P. L. (2021) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000713 · Cited by 44
SeqScreen: accurate and sensitive functional screening of pathogenic sequences via ensemble learning
Balaji, A., Kille, B. L., Kappell, A. D., Godbold, G. D., Diep, M. M., Elworth, R. A. L., Qian, Z., Albin, D., Nasko, D. J., Shah, N., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02695-x · Cited by 45
Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality
de Brabander, J., Boers, L. S., Kullberg, R. F. J., Zhang, S., Nossent, E. J., Heunks, L. M. A., Vlaar, A. P. J., Bonta, P. I., Schultz, M. J., van der Poll, T., et al. (2023) · Thorax · doi:10.1136/thorax-2023-219989 · Cited by 39
Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection
Maurya, V. K., Kumar, S., Bhatt, M. L. B., & Saxena, S. K. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1832577 · Cited by 42
Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
Vagapova, E. R., Lebedev, T. D., & Prassolov, V. (2021) · Scientific Reports · doi:10.1038/s41598-021-90701-w · Cited by 43
On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 Update
Camps, J., Castañé, H., Rodríguez‐Tomàs, E., Baiges‐Gayà, G., Hernández‐Aguilera, A., Arenas, M., Iftimie, S. M., & Joven, J. (2021) · Biomolecules · doi:10.3390/biom11070971 · Cited by 43
A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis
Xie, Y., Peng, C.-W., Su, Z., Huang, H.-T., Liu, X., Zhan, S., & Huang, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.769011 · Cited by 42
SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147
Shouman, S., Elkholy, N., Hussien, A. E., El-Derby, A. M., Magdy, S., Abou‐Shanab, A. M., Elmehrath, A. O., Abdelwaly, A., Helal, M. A., & El‐Badri, N. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01718-3 · Cited by 47
A CRISPR-Cas12a-mediated dual-mode luminescence and colorimetric nucleic acid biosensing platform based on upconversion nanozyme
Yan, J., Yin, B., Zhang, Q., Li, C., Chen, J., Huang, Y., Hao, J., Yi, C., Zhang, Y., Wong, S. H. D., et al. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116963 · Cited by 42
Self-citation
The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro
Okamoto, M., Toyama, M., & Baba, M. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104902 · Cited by 41
A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients
Sadanandam, A., Bopp, T., Dixit, S., Knapp, D. J. H. F., Emperumal, C. P., Vergidis, P. I., Rajalingam, K., Melcher, A. A., & Kannan, N. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00376-x · Cited by 39
Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19
Tomazou, M., Bourdakou, M. M., Minadakis, G., Zachariou, M., Oulas, A., Karatzas, E., Loizidou, E. M., Kakouri, A. C., Christodoulou, C. C., Savva, K., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab114 · Cited by 44
Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseases
Satu, M. S., Khan, M. I., Rahman, M. R., Howlader, K. C., Roy, S., Roy, S. S., Quinn, J. M. W., & Moni, M. A. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab003 · Cited by 41
Can COVID 2019 induce a specific cardiovascular damage or it exacerbates pre-existing cardiovascular diseases?
Mansueto, G., Niola, M., & Claudio Napoli, A. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.153086 · Cited by 42

Authors: Xiong, Y., Liu, Y., Cao, L., Wang, D., Guo, M., Jiang, A., Guo, D., Hu, W., Yang, J., Tang, Z., Wu, H., Lin, Y., Zhang, M., Zhang, Q., Shi, M., Liu, Y., Zhou, Y., Lan, K., & Chen, Y.
Affiliations: Wuhan University (CN)
Sun Yat-sen University (CN)
BGI Group (China) (CN)
State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University
The Centre for Infection and Immunity Studies, School of Medicine, Sun Yat-sen University
Corresponding author: Zhou, Yu
Lan, Ke
Chen, Yu
ORCID: Xiong, Yong
Liu, Yuan
Cao, Liu
Wang, Dehe
Guo, Ming
Jiang, Ao
Guo, Dong
Hu, Wenjia
Yang, Jiayi
Wu, Honglong
Lin, Yongquan
Zhang, Qi
Liu, Yingle
Zhou, Yu
Lan, Ke
Chen, Yu
Venue: Emerging Microbes & Infections
Publisher: Informa UK Limited
Published: 2020-01
Volume: 9
Issue: 1
Pages: 761-770
ISSN: 2222-1751 (ISSN-L)
DOI: 10.1080/22221751.2020.1747363
PMC: PMC7170362
OpenAlex: W3013843138
Cited by: 1,076
References: 53
Citations by year: 2026: 12 · 2025: 27 · 2024: 68 · 2023: 121 · 2022: 206 · 2021: 370 · 2020: 272
FWCI: 31.89
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (unspecified)
Locations: Emerging Microbes & Infections (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
Funders: National Natural Science Foundation of China (31871316, COVID-19)
Wuhan University
National Science and Technology Major Project (#2018ZX10733403)
Topics: Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
Keywords: COVID-19 pandemic, SARS-CoV-2, bronchoalveolar lavage fluid, peripheral blood mononuclear cells, host immune response, inflammatory cytokines, chemokines, lymphopenia, apoptosis, p53 pathway, lymphocyte activation, transcriptome
MeSH terms: Betacoronavirus, RNA-Seq, COVID-19, SARS-CoV-2, Bronchoalveolar Lavage Fluid, Humans, Leukocytes, Mononuclear, Lymphopenia, Pneumonia, Viral, Signal Transduction, Tumor Suppressor Protein p53, Cytokines, Apoptosis, Coronavirus Infections, Chemokines, Pandemics, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks